At Harmonic Pharma, we believe that the polypharmacology based technology that we have developed is a powerful way of revisiting safe drugs by de-risking R&D and accelerating market access.

Current achievements demonstrate maturity of our approach in delivering fast and robust results more cost effectively than in the past. Thus, new collaboration models are explored with interested stakeholders.

For instance, it makes it possible for pharma and biotech companies:

  • to license in HPH drug candidates at any stage of their R&D.
  • to participate in funding a phase I/II clinical stage that is necessary to get a Proof of Concept in man before licensing in.

If you are interested, please contact us.